54 results
6-K
AUTL
Autolus Therapeutics plc
7 May 20
Index to Condensed Consolidated Financial Statements
12:00am
of health epidemics, including the recent global coronavirus COVID-19 pandemic, in regions where we, or the third parties on which we rely, have business … a pandemic. The U.S. government also has imposed travel restrictions on travel between the United States, United Kingdom and certain other countries
6-K
EX-99.1
AUTL
Autolus Therapeutics plc
4 Aug 22
Index to Condensed Consolidated Financial Statements
4:06pm
will be achieved or that the Company can obtain additional funding on terms acceptable to the Company, or at all.
Impact of COVID-19 Pandemic
While … the Company has not experienced any significant financial impact to date, as a result of the ongoing coronavirus 2019 (“COVID-19”) pandemic, the overall
6-K
EX-99.1
AUTL
Autolus Therapeutics plc
5 May 22
Index to Condensed Consolidated Financial Statements
12:00am
is exercisable in whole or in part until November 6, 2026.
Impact of COVID-19 Pandemic
While the Company has not experienced any significant financial … impact to date, as a result of the ongoing coronavirus 2019 (“COVID-19”) pandemic, the overall disruption caused by the COVID-19 pandemic on global
6-K
EX-99.2
AUTL
Autolus Therapeutics plc
5 Nov 20
Index to Condensed Consolidated Financial Statements
4:03pm
Update
With the global spread of the ongoing coronavirus 2019, or COVID-19, pandemic, we established a cross-functional task force and have … financial impact to date, the overall disruption caused by the COVID-19 pandemic on global healthcare systems, and the other risks and uncertainties
6-K
EX-99.1
AUTL
Autolus Therapeutics plc
3 Nov 22
Index to Condensed Consolidated Financial Statements
10:31am
Pandemic
While the Company has not experienced any significant financial impact to date as a result of the ongoing coronavirus 2019 (“COVID-19 … ”) pandemic, the overall disruption caused by the COVID-19 pandemic on global healthcare systems, and the other risks and uncertainties associated
6-K
EX-99.1
jjrhh4tbodk90 0qpkh
7 Dec 20
Updated data from the ALLCAR study suggests AUTO1’s potential for transformational activity in adult patients with r/r ALL
4:00pm
6-K
EX-99.2
qacw0gp
5 May 22
Index to Condensed Consolidated Financial Statements
12:00am
6-K
EX-99.2
jun62ps
3 Nov 22
Index to Condensed Consolidated Financial Statements
10:31am
6-K/A
EX-99.2
bx6888587qyf kdvj9
21 Nov 22
Current report (foreign) (amended)
4:03pm
6-K
EX-99.2
18fuasfa0ys4
4 Aug 22
Index to Condensed Consolidated Financial Statements
4:06pm
6-K
EX-1
3kgl xe9sbks9b
30 Jun 21
Annual Report and Accounts
6:05am
6-K
EX-99.1
4s5z9x2d
19 Apr 21
Autolus Therapeutics announces appointment of Martin Murphy as Non-executive Chairman
4:45pm
6-K
EX-99.1
e542j7f 16
6 May 21
Index to Condensed Consolidated Financial Statements
4:05pm
6-K
EX-99.2
4qxx zmctq
6 May 21
Index to Condensed Consolidated Financial Statements
4:05pm
6-K
EX-99.1
718rzlhduq7qak
5 Aug 21
Index to Condensed Consolidated Financial Statements
4:04pm
6-K
EX-99.2
tgl6z5
6 Aug 20
Current report (foreign)
4:06pm
6-K
EX-99.1
zqobsalyqt
5 Nov 20
Index to Condensed Consolidated Financial Statements
4:03pm
6-K
EX-99.1
xnbezx0kmr661c
3 Nov 21
Index to Condensed Consolidated Financial Statements
4:05pm
6-K
EX-99.1
lk2m8hcav c09
15 Sep 21
Autolus Therapeutics announces the appointment of John H. Johnson as non-executive chairman of its Board of Directors
4:30pm
6-K
EX-99.1
11h7sjj4u20duca o471
11 Jan 22
Autolus Therapeutics announces retirement of chief financial officer and succession plan
4:33pm